Multi-Center Registry Trial of EXCEL Rapamycin Biodegradable Polymer Drug-Eluting Stent.

Trial Profile

Multi-Center Registry Trial of EXCEL Rapamycin Biodegradable Polymer Drug-Eluting Stent.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CREATE
  • Most Recent Events

    • 21 May 2012 Actual end date changed from 31 Dec 2006 to 31 Dec 2007 as reported by Chinese Clinical Trial Register.
    • 22 Jun 2009 New source identified and integrated (Chinese Clinical Trial Register).
    • 22 Jun 2009 JW Medical Systems added as sponsor, additional lead trial centres identified as reported by Chinese Clinical Trial Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top